Steadview Capital sells Syngene Int'l shares for Rs 100-cr

Steadview Capital today offloaded 19.5 lakh shares of Syngene International, a leading contract research and manufacturing firm, for a little over Rs 100 crore through open market transactions.

The shares were purchased by UTI Mutual Fund and Gaoling Fund LP.

According to the block deal data available with the BSE, Steadview Capital Mauritius sold 19.5 lakh shares, amounting to 0.97 per cent stake, of the leading contract research and manufacturing firm.

The shares were sold on an average price of Rs 515, valuing the transaction at Rs 100.42 crore.

In December last year, Steadview Capital had picked up 30 lakh shares of Syngene International for over Rs 172 crore.
 

As per the latest shareholding disclosure with the exchange, Steadview Capital held 1.5 per cent stake in Syngene International.

Shares of Syngene International today closed at Rs 518.60 per unit on BSE, down 0.64 per cent from the previous close.